TRANS-2-(TRIFLUOROMETHYL)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 100mg

3-Chloro-2-fluorobenzonitrile, 98.0%, 10g

8-Bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine, 95.0%, 250mg

(S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butanoic acid, 97%, 1g

tert-Butyl 2-(methylthio)-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate, 97%, 250mg

6-Chloro-4-methylpyridazin-3(2H)-one, 95.0%, 25g

2-Amino-4-nitrobenzenemethanol, 98.0%, 5g

4-Bromo-1-naphthaleneboronic Acid (contains varying amounts of Anhydride)1g

(S)-Methyl 2-amino-3-(pyridin-3-yl)propanoate dihydrochloride, 98%, 500mg

Methyl 6-amino-4-bromopicolinate, 95.0%, 1g

1H,1H,5H-Octafluoropentyl Methacrylate (stabilized with MEHQ)>98.0%(GC)25g

2-(Difluoromethyl)-5-fluorobenzoic acid, 98%, 100mg

Phenyl beta-D-Galactopyranoside>98.0%(HPLC)1g